Skip to main content
. 2023 Jan 7;23:12. doi: 10.1186/s12884-022-05329-z

Table 1.

Patient Characteristics Among 155 HDFN Groups, Including Mothers, Neonates, and Fetuses, From 60 Included Studis

Characteristic Mean (± SD, Range) Patient Groups (n) No. of Studies (References)
Patient group size, n 36.5 (± 68.7, 1.0–334.0) 146a 60 [2, 2280]
Gestational age at birth, weeksb
 Mean gestational age 35.1 (± 2.1, 33.0–37.4) 13 9 [23, 26, 28, 47, 53, 63, 65, 70, 72]
 Median gestational age 35.4 (± 2.1, 28.0–37.0) 24 12 [31, 35, 42, 45, 51, 59, 60, 62, 63, 75, 76]
 Exact gestational age 34.1 (± 2.9, 28.1–38.0) 18 14 [22, 24, 27, 34, 39, 43, 44, 46, 50, 52, 55, 66, 74, 77]
Gestational age at first IUT, weeks
 Mean gestational age 26.6 (± 0.1, 26.6–26.7) 4 2 [28, 53]
 Median gestational age 25.9 (± 3.4, 21.7–36.3) 27 13 [31, 51, 5961, 63, 64, 69, 73, 75, 79, 80]
 Exact gestational age 24.8 (± 3.9, 20.0–30.1) 8 5 [44, 52, 66, 68, 76]

Means, medians, and exact gestational age as reported in each study were used to calculate mean (range)

HDFN Hemolytic disease of the fetus and newborn, IUT Intrauterine transfusion

aOf the 155 patient groups, 46 (29.7%) groups were single patients from case reports

bDoes not include 1 study [2] in which the reported percentage of the patient group fell within gestational age ranges (i.e., < 259 days and 259–294 days)